Long-term efficacy of biologics in dermatology.

Long-term efficacy of biologics in dermatology.

Item
http://www.wikidata.org/entity/Q37394846
An evidence-based review of skin cancer rates on biologic therapies.How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.Biologics in children's autoimmune disorders: efficacy and safety.Psoriasis: from pathogenesis to novel therapeutic approaches.New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab.Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.An Update on Medical Treatment Options for Hidradenitis Suppurativa.Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria.Biological therapy of psoriasis.Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis.Etanercept, Adalimumab und Ustekinumab bei Psoriasis: Analyse von 209 Behandlungsreihen in Österreich.
P2860

Long-term efficacy of biologics in dermatology.

Item
http://www.wikidata.org/entity/Q37394846
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term efficacy of biologics in dermatology.
@en
Long-term efficacy of biologics in dermatology.
@nl
type
label
Long-term efficacy of biologics in dermatology.
@en
Long-term efficacy of biologics in dermatology.
@nl
prefLabel
Long-term efficacy of biologics in dermatology.
@en
Long-term efficacy of biologics in dermatology.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Long-term efficacy of biologics in dermatology.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1529-8019.2008.01213.X
P433
P478
P577
P5875
P698
P932